BioMedTracker's JPM Drug News: Day 2
This article was originally published in Scrip
Every day of the 34th annual JP Morgan Healthcare Conference in San Francisco, analysts from BioMedTracker – an affiliate of Scrip Intelligence – produce a report detailing the drug events and catalysts that are announced or updated at the meeting. See below for the highlights, and click on the link at the bottom for a complimentary copy of the full report.
You may also be interested in...
A WHO recommendation to explicitly exempt low-THC CBD from international narcotics controls has been emphatically rejected by UN member states. The CBD industry had hoped for a positive outcome to remove regulatory pressure on product manufacturers in Europe and around the world.
After its historic first emergency approval, analysts at Bernstein has upgraded predictions for Pfizer/BioNTech's COVID-19 vaccine in 2021 and beyond.
How UK and EU device regulations will differ in 2021, UK approved bodies and Northern Ireland's unfettered access to the UK market were key themes at the ABHI’s annual regulatory conference.